GlassScriptPhysician profile
Anil Sharma
NPI 1497172530
$14,495.76
in general payments reported to CMS, 2019-2025
10 companies · $14K in 2025
The $14K reported for 2025 was more than what 94% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2021: $56.90 · 2022: $59.46 · 2023: $19.00 · 2024: $441 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Travel and Lodging: $2,106 · Food and Beverage: $1,148.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,000.00 |
| Travel and Lodging | $2,106.46 |
| Food and Beverage | $1,148.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $13,430.31 | 2025 | Tremfya, Stelara |
| Abbvie INC. | $475.56 | 2022-2024 | |
| Janssen Scientific Affairs, LLC | $249.85 | 2019-2025 | |
| Madrigal Pharmaceuticals | $144.00 | 2025 | Rezdiffra |
| Medtronic, INC. | $56.90 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $49.63 | 2025 | Entyvio |
| Cook Medical LLC | $25.20 | 2024 | Hemospray |
| Amgen INC. | $23.78 | 2025 | Uplizna |
| Djo, LLC | $21.53 | 2025 | Cmf |
| Boston Scientific Corporation | $19.00 | 2023 | Captivator II |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anil Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.